| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: HETC |
| Security Type |
Common Stock |
| Lead Underwriter |
UBS Warburg Credit Suisse First Boston |
| Days In Registration |
91 |
| Date Filed |
12-Apr-2002 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Pers/Bus/Rep Svc |
| Business Description |
Develop diagnostic devices and software for measuring and monitoring health parameters; manufacture health monitoring devices |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
19.46M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
5.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
5.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
600.0K |
| File Amount |
$75.0M |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
Current Filing Information
(Amended 18-Jun-2002) |
|
US |
|
Shares Filed |
5.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
5.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$60.0M |
| · % Change from Original |
-20.0 |
| File Price Range |
$13.00 - $11.00 |
| File Mid Price |
$12.00 |
|
